6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure
Authors:
- Yuto KawaseYKYuto Kawase
- Yoichi SunagawaYSYoichi Sunagawa
- Kana ShimizuKSKana Shimizu
- Masafumi FunamotoMFMasafumi Funamoto
- Toshihide Hamabe-HoriikeTHToshihide Hamabe-Horiike
- Yasufumi KatanasakaYKYasufumi Katanasaka
- Satoshi ShimizuSSSatoshi Shimizu
- Philip HawkePHPhilip Hawke
- Kiyoshi MoriKMKiyoshi Mori
- Maki KomiyamaMKMaki Komiyama
- Koji HasegawaKHKoji Hasegawa
- Tatsuya MorimotoTMTatsuya Morimoto
Open Access
Abstract
Hypertrophic stress-induced cardiac remodeling is a compensatory mechanism associated with cardiomyocyte hypertrophy and cardiac fibrosis. Continuation of this response eventually leads to heart failure. The histone acetyltransferase p300 plays an important role in the development of heart failure, and may be a target for heart failure therapy. The phenolic phytochemical 6-shogaol, a pungent component of raw ginger, has various bioactive effects; however, its effect on cardiovascular diseases has not been investigated. One micromolar of 6-shogaol suppressed phenylephrine (PE)-induced increases in cardiomyocyte hypertrophy in rat primary cultured cardiomyocytes. In rat primary cultured cardiac fibroblasts, 6-shogaol suppressed transforming growth factor-beta (TGF-β)-induced increases in L-proline incorporation. It also blocked PE- and TGF-β-induced increases in histone H3K9 acetylation in the same cells and in vitro. An in vitro p300-HAT assay revealed that 6-shogaol suppressed histone acetylation. The mice underwent transverse aortic constriction (TAC) surgery, and were administered 0.2 or 1 mg/kg of 6-shogaol daily for 8 weeks. 6-shogaol prevented TAC-induced systolic dysfunction and cardiac hypertrophy in a dose-dependent manner. Furthermore, it also significantly inhibited TAC-induced increases in histone H3K9 acetylation. These results suggest that 6-shogaol may ameliorate heart failure through a variety of mechanisms, including the inhibition of p300-HAT activity.Keywords
Funding Information
- Japan Science and Technology Agency (20K07070, 19K16396, 21K08069)
- Cardiovascular Research Fund (20K07070, 19K16396, 21K08069)
- Japan Heart Foundation Research Grant (20K07070, 19K16396, 21K08069)
- Nutrition and Food Science Fund of the Japan Society of Nutrition and Food Science (20K07070, 19K16396, 21K08069)
- Mochida Memorial Foundation for Medical and Pharmaceutical Research (20K07070, 19K16396, 21K08069)
This publication has 53 references indexed in Scilit:
- Angiotensin-(1–7) abrogates mitogen-stimulated proliferation of cardiac fibroblastsPeptides, 2012
- Cyclin-dependent Kinase-9 Is a Component of the p300/GATA4 Complex Required for Phenylephrine-induced Hypertrophy in CardiomyocytesJournal of Biological Chemistry, 2010
- 6‐Shogaol suppressed lipopolysaccharide‐induced up‐expression of iNOS and COX‐2 in murine macrophagesMolecular Nutrition & Food Research, 2008
- Quantitative Control of Adaptive Cardiac Hypertrophy by Acetyltransferase p300Circulation, 2008
- Pharmacokinetics of 6-Gingerol, 8-Gingerol, 10-Gingerol, and 6-Shogaol and Conjugate Metabolites in Healthy Human SubjectsCancer Epidemiology, Biomarkers & Prevention, 2008
- The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in ratsJournal of Clinical Investigation, 2008
- Dynamic changes in chromatin acetylation and the expression of histone acetyltransferases and histone deacetylases regulate the SM22α transcription in response to Smad3-mediated TGFβ1 signalingBiochemical and Biophysical Research Communications, 2006
- Histone Acetyltransferase Activity of p300 Is Required for the Promotion of Left Ventricular Remodeling After Myocardial Infarction in Adult Mice In VivoCirculation, 2006
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Cardiac p300 Is Involved in Myocyte Growth with Decompensated Heart FailureMolecular and Cellular Biology, 2003